stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
무료 - Play StoreApp Store
설치하다설치하다
logo
Dow:  
Nasdaq:  
S&P 500:  
Edwards Lifesciences CorpEW
$94.773.00%2.76

Edwards Lifesciences Corp (EW)

Date: 2026-11-02 16:00O: 93.49H: 94.84L: 92.85C: 94.82Vol: 1.385M
전일 마감가:
$92.01
열려 있는:
$93.49
하루 거래량:
1,574,054
상대 거래량:
0.48
시가총액:
$54.63B
수익:
$6.30B
순이익/손실:
$1.07B
주가수익비율:
51.49
EPS:
$1.84
순현금흐름:
$1.09B
1W 성능:
+4.65%
1M 성능:
+11.30%
6M 성능:
+12.85%
1Y 성능:
+14.94%
1일 변동 폭
$92.85$94.80
1주일 범위
$89.73$95.34
52주 변동 폭
$74.66$96.29

Edwards Lifesciences Corp 주식 (EW) 회사 개요

명칭
Edwards Lifesciences Corp
부문
Healthcare
산업
Medical Devices
전화
(949) 250-2500
주소
ONE EDWARDS WAY, IRVINE, CA, USA
직원
16,000
X
@edwardslifesci
다음 수익 날짜
2026-11-04
최신 SEC 제출 서류
SEC
X에서 EW에 대한 토론
X

EW vs ABT, MDT, SYK, BSX 비교

주식시가총액매출순이익현금흐름주당 순 이익
EW
Edwards Lifesciences Corp
$54.65B$6.51B$1.00B$1.09B$1.84
ABT
Abbott Laboratories
$187.83B$45.13B$6.28B$7.38B$3.09
MDT
Medtronic Plc
$125.06B$37.54B$5.23B$5.43B$3.73
SYK
Stryker Corp
$116.26B$26.30B$3.62B$4.57B$8.63
BSX
Boston Scientific Corp
$63.11B$21.00B$3.67B$3.48B$2.38

Edwards Lifesciences Corp 주식(EW) 업그레이드 및 다운그레이드

날짜액션분석자등급 변경
2026-10-07개시BarclaysOverweight
2026-07-28개시UBSBuy
2026-07-24업그레이드Leerink PartnersMarket Perform → Outperform
2026-04-01업그레이드Wolfe ResearchPeer Perform → Outperform

Edwards Lifesciences Corp (EW) 재무 분석

기간추세FY 2025FY 2024FY 2023FY 2022FY 2021
기간 종료일2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)6,067.605,439.506,004.805,382.405,232.50
Cost of revenue USD (M)1,334.201,117.501,379.801,080.401,248.90
Gross profit USD (M)4,733.404,322.004,625.004,302.003,983.60
Research and development USD (M)1,079.201,053.001,071.80945.20903.10
Operating expenses USD (M)--3,090.902,553.502,293.30
Operating income USD (M)1,264.201,378.701,534.101,748.501,690.30
Income before tax USD (M)1,272.901,548.101,598.101,767.401,702.00
Income tax expense USD (M)216.90152.10198.70245.50198.90
Net income USD (M)1,069.404,169.701,399.401,521.901,503.10
Basic EPS USD/shares1.846.982.312.462.41
Diluted EPS USD/shares1.836.972.302.442.38
Basic weighted shares shares (M)584.80597.70606.70619.00623.30
Diluted weighted shares shares (M)585.80599.30609.40624.20631.20
Selling, general and administrative USD (M)2,085.201,789.201,824.601,567.601,493.70

Edwards Lifesciences Corp 주식 (EW) 내부자 거래

  • Lippis Daniel J.Oct 08 '26
    CVP, TAVR
    거래
    Sale
    비용
    $85.65
    #주식
    619
    가치 ($)
    53,017
    #주식 총계
    40,034
  • Lippis Daniel J.Sep 11 '26
    CVP, TAVR
    거래
    Option Exercise
    비용
    $72.68
    #주식
    619
    가치 ($)
    44,989
    #주식 총계
    40,653
  • Lippis Daniel J.Sep 11 '26
    CVP, TAVR
    거래
    Sale
    비용
    $87.51
    #주식
    619
    가치 ($)
    54,169
    #주식 총계
    40,034
  • Dahl Andrew M.Aug 31 '26
    SVP, Corporate Controller
    거래
    Sale
    비용
    $91.06
    #주식
    544
    가치 ($)
    49,534
    #주식 총계
    14,868
  • Dahl Andrew M.Aug 31 '26
    Officer
    거래
    Proposed Sale
    비용
    $91.06
    #주식
    544
    가치 ($)
    49,534
    #주식 총계
    0
  • Bruls AnnetteAug 28 '26
    CVP, EMEACLA
    거래
    Sale
    비용
    $89.98
    #주식
    2,644
    가치 ($)
    237,907
    #주식 총계
    17,984
  • Bruls AnnetteAug 28 '26
    Officer
    거래
    Proposed Sale
    비용
    $89.98
    #주식
    2,644
    가치 ($)
    237,907
    #주식 총계
    0
  • Markowitz WayneAug 26 '26
    CVP, JAPAC
    거래
    Sale
    비용
    $91.47
    #주식
    1,240
    가치 ($)
    113,417
    #주식 총계
    20,294
  • Markowitz WayneAug 26 '26
    Officer
    거래
    Proposed Sale
    비용
    $91.47
    #주식
    1,240
    가치 ($)
    113,417
    #주식 총계
    0
  • Chopra DaveenAug 26 '26
    Officer
    거래
    Proposed Sale
    비용
    $91.02
    #주식
    31,800
    가치 ($)
    2,894,440
    #주식 총계
    0
내부자 거래관계날짜거래비용#주식가치 ($)#주식 총계
Lippis Daniel J.CVP, TAVROct 08 '26Sale$85.6561953,01740,034
Lippis Daniel J.CVP, TAVRSep 11 '26Option Exercise$72.6861944,98940,653
Lippis Daniel J.CVP, TAVRSep 11 '26Sale$87.5161954,16940,034
Dahl Andrew M.SVP, Corporate ControllerAug 31 '26Sale$91.0654449,53414,868
Dahl Andrew M.OfficerAug 31 '26Proposed Sale$91.0654449,5340
Bruls AnnetteCVP, EMEACLAAug 28 '26Sale$89.982,644237,90717,984
Bruls AnnetteOfficerAug 28 '26Proposed Sale$89.982,644237,9070
Markowitz WayneCVP, JAPACAug 26 '26Sale$91.471,240113,41720,294
Markowitz WayneOfficerAug 26 '26Proposed Sale$91.471,240113,4170
Chopra DaveenOfficerAug 26 '26Proposed Sale$91.0231,8002,894,4400

Edwards Lifesciences Corp 주식(EW)의 최신 뉴스

Nov 01, 2026

Medtronic Just Retired 55 Million Shares Without Spending Cash. Is the Stock a Buy? - The Motley Fool

Nov 01, 2026
Oct 30, 2026

Edwards' Q3 Earnings on the Horizon: What's in the Cards? - Zacks Investment Research

Oct 30, 2026
Oct 29, 2026

NCH Rooney Heart Institute Performs Nation’s First Tricuspid Valve Repair with PASCAL Precision System Following FDA Approval - GlobeNewswire Inc.

Oct 29, 2026
Oct 28, 2026

SYK Q3 Earnings: Can Recovery Momentum Offset Operational Headwinds? - Zacks Investment Research

Oct 28, 2026
Oct 28, 2026

ProDex Q1 Earnings Preview: Can Strong Sales Momentum Sustain Growth? - Zacks Investment Research

Oct 28, 2026
Oct 27, 2026

TD Cowen reiterates Buy on Edwards Lifesciences stock, $104 target - Investing.com

Oct 27, 2026
Oct 26, 2026

$100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today - Benzinga

Oct 26, 2026
Oct 26, 2026

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 26, 2026
Oct 26, 2026

Edwards Expands Pascal System to Tricuspid Valve Disease - Orange County Business Journal

Oct 26, 2026
Oct 26, 2026

Edwards Lifesciences Corporation $EW Stock: Robeco Schweiz AG Grows Position - MarketBeat

Oct 26, 2026
Oct 23, 2026

Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch

Oct 23, 2026
Oct 23, 2026

INSP Stock Gains 47.8% in Three Months: What's Driving the Rally? - Zacks Investment Research

Oct 23, 2026
Oct 23, 2026

Evercore ISI Raises Price Target for Edwards Lifesciences (EW) t - GuruFocus

Oct 23, 2026
Oct 22, 2026

DaVita Stock Gains 55.6% Year to Date: What's Behind the Rally? - Zacks Investment Research

Oct 22, 2026
Oct 22, 2026

Edwards Lifesciences faces stock risk ahead of trial results says Stifel - Investing.com

Oct 22, 2026
Oct 21, 2026

Edwards Lifesciences wins FDA approval for PASCAL tricuspid repair - Mugglehead Investment Magazine

Oct 21, 2026
Oct 21, 2026

Edwards Lifesciences Gets Approval for Tricuspid Valve Repair System From US FDA - marketscreener.com

Oct 21, 2026
Oct 21, 2026

FDA Approval of Edwards Lifesciences' PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease - Finviz

Oct 21, 2026
Oct 20, 2026

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 20, 2026
Oct 16, 2026

Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch

Oct 16, 2026
Oct 16, 2026

FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death - Benzinga

Oct 16, 2026
Oct 16, 2026

FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death - Yahoo Finance Singapore

Oct 16, 2026
Oct 16, 2026

Edwards Lifesciences Corporation $EW Stock: Assenagon Asset Management S.A. Boosts Stake - MarketBeat

Oct 16, 2026
Oct 16, 2026

FDA flags Edwards heart-valve delivery system issue after death, injury - Reuters

Oct 16, 2026
Oct 16, 2026

FDA issues early alert for Edwards Lifesciences’ mitral valve delivery system after reported death, injury - Fierce Biotech

Oct 16, 2026
Oct 16, 2026

Edwards recall of Sapien mitral delivery systems tied to 1 death - MedTech Dive

Oct 16, 2026
Oct 15, 2026

Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Oct 15, 2026
Oct 15, 2026

Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Oct 15, 2026
Oct 15, 2026

Edwards Lifesciences Corporation $EW Stock Sold by Ninety One UK Ltd - MarketBeat

Oct 15, 2026
Oct 15, 2026

Edwards Lifesciences Corporation $EW Shares Sold by Ninety One North America Inc. - MarketBeat

Oct 15, 2026
Oct 15, 2026

Baird Adjusts Price Target on Edwards Lifesciences to $90 From $94 - Yahoo Finance

Oct 15, 2026
Oct 14, 2026

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 14, 2026
Oct 14, 2026

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 14, 2026
Oct 12, 2026

Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Oct 12, 2026
Oct 12, 2026

Edwards Lifesciences Earnings Preview: What to Expect - Yahoo Finance

Oct 12, 2026
Oct 12, 2026

Edwards Lifesciences Earnings Preview: What to Expect - Barchart.com

Oct 12, 2026
Oct 12, 2026

Edwards Lifesciences Earnings Preview: What to Expect - inkl

Oct 12, 2026
Oct 09, 2026

Edwards Lifesciences Corporation (EW) Options Chain - Yahoo Finance - Yahoo! Finance Canada

Oct 09, 2026
Oct 09, 2026

Edwards Lifesciences Corporation (EW) Options Chain - Yahoo! Finance Canada

Oct 09, 2026
Oct 09, 2026

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Oct 09, 2026
Oct 09, 2026

Edwards Lifesciences CVP Daniel Lippis sells $53k in stock - Investing.com

Oct 09, 2026
Oct 08, 2026

Edwards Lifesciences Corp (EW) Insider Daniel Lippis Sells 619 S - GuruFocus

Oct 08, 2026
Oct 08, 2026

Edwards Lifesciences (NYSE:EW) VP Daniel Lippis Sells 619 Shares of Stock - MarketBeat

Oct 08, 2026
Oct 08, 2026

Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors - MarketWatch

Oct 08, 2026
Oct 08, 2026

Is Edwards Lifesciences (NYSE:EW) Entering A Stronger Phase? - Kalkine Media

Oct 08, 2026
Oct 08, 2026

Why Edwards Lifesciences (EW) Stock Is Falling Today - Quiver Quantitative

Oct 08, 2026
Oct 08, 2026

UBS reiterates Edwards Lifesciences stock rating on endpoint expectations - Investing.com

Oct 08, 2026
Oct 08, 2026

Edwards Lifesciences (EW) Stock Forecast and Price Target 2026 $EW - MarketBeat

Oct 08, 2026
Oct 07, 2026

Can ISRG's Single-Port Platform Become the Next Billion-Dollar Franchise? - Zacks Investment Research

Oct 07, 2026
Oct 07, 2026

Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026 - BioSpace

Oct 07, 2026

EW와(과) 유사한 종목

BSXBSX$43.493.60%GEHCGEHC$80.064.55%DXCMDXCM$84.042.12%PHGPHG$27.401.76%STESTE$231.021.72%ZBHZBH$96.582.18%